News_CAIVD & PCEM

Mindray Has Agreed to Acquire 75% Stake in Germany-Based DiaSys Diagnostic Systems GmbH

2023/8/1 11:54:57　Views：789

Original from: Mindray

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. ( “Mindray”) has agreed to acquire 75% equity interest in DiaSys Diagnostic Systems GmbH (“DiaSys”) from Gorka Holding GmbH, through Mindray Medical Netherlands B.V. (“Mindray Netherlands”), a wholly-owned subsidiary of Mindray’s wholly-owned subsidiary MR Global (HK) Limited, for an all-cash preliminary purchase price of approx. €115 million.

The final purchase price will be determined as of closing. Upon completion of the proposed transaction, Mindray will hold 75% equity interest in DiaSys and consolidate DiaSys and its subsidiaries. Upon closing, Mindray Netherlands and Gorka Holding GmbH will proportionally contribute €40 million to DiaSys, which will be used to support DiaSys’ future business development.

Established in 1991 and headquartered in Holzheim, Germany, DiaSys is a globally recognized brand with over three decades of expertise in the fields of in vitro diagnostics (“IVD”). DiaSys has production facilities across Europe, APAC, and Latin America.

Going forward, Mindray will leverage DiaSys’ global supply platforms and international team of professionals to expedite overseas supply chain construction, in order to achieve the further expansion into medium to large volume customer segments worldwide, and offer more timely and comprehensive professional service to clients.

At the same time, DiaSys’ extensive experience in clinical chemistry is also expected to bring synergies to Mindray's IVD business. DiaSys’s ability to develop and produce IVD controls and calibrators will complement Mindray’s IVD product offering and enhance its system performance.

Closing of the proposed transaction is subject to customary regulatory approval as well as satisfaction of certain conditions agreed by the parties.

About Mindray

Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. With a customer-oriented approach, we are committed to providing top-notch products and services to medical institutions worldwide. By integrating innovation and addressing clinical needs, Mindray supports healthcare providers in delivering high-quality medical services, while enhancing global healthcare conditions. Over the years, Mindray has evolved into the largest medical device and solution provider in China and a global leader in the industry.

About DiaSys

DiaSys is a leading specialist in the development and manufacturing of diagnostic system solutions of highest quality, trusted by customers in more than 140 countries for over 30 years. Its product portfolio comprises more than 90 clinical chemistry and immunoturbidimetric reagents for routine and special diagnostics including suitable calibrators and controls as well as instrumentation products.

Source: Mindray Has Agreed to Acquire 75% Stake in Germany-Based DiaSys Diagnostic Systems GmbH

Prev：AmoyDx Signed a Collaboration Agreement with AstraZeneca for HRD Companion Diagnostic Next：Abbott's China Executive Changes